Patents by Inventor Gary Peter Anderson

Gary Peter Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATMENT AND AGENTS USEFUL FOR SAME
    Publication number: 20150368348
    Abstract: The present invention relates generally to a method for the treatment and prophylaxis of inflammatory conditions. The present invention is predicated in part on the identification of cells of the monocyte/macrophage lineage being critical for inflammation and, in particular, chronic inflammation. In accordance with the present invention, it is proposed that the reduction in levels of monocyte/macrophage-type cells and/or a reduction in the production of inflammatory and pro-inflammatory mediators by these cells, especially locally, is effective in reducing inflammatory conditions. The present invention further provides animal models useful for screening for reducing levels of monocyte/macrophage-type cells and/or reducing the production of inflammatory and pro-inflammatory mediators of these cells.
    Type: Application
    Filed: May 19, 2015
    Publication date: December 24, 2015
    Inventors: John Allan Hamilton, Gary Peter Anderson, Ian Keith Campbell
  • Method of treatment and agents useful for same
    Publication number: 20120177654
    Abstract: The present invention relates generally to a method for the treatment and prophylaxis of inflammatory conditions. The present invention is predicated in part on the identification of cells of the monocyte/macrophage lineage being critical for inflammation and, in particular, chronic inflammation. In accordance with the present invention, it is proposed that the reduction in levels of monocyte/macrophage-type cells and/or a reduction in the production of inflammatory and pro-inflammatory mediators by these cells, especially locally, is effective in reducing inflammatory conditions. The present invention further provides animal models useful for screening for reducing levels of monocyte/macrophage-type cells and/or reducing the production of inflammatory and pro-inflammatory mediators of these cells.
    Type: Application
    Filed: December 23, 2011
    Publication date: July 12, 2012
    Applicant: THE UNIVERSITY OF MELBOURNE
    Inventors: John Hamilton, Gary Peter Anderson, Ian Keith Campbell
  • Method of treatment and agents useful for same
    Patent number: 7455836
    Abstract: The present invention relates generally to a method for the treatment and prophylaxis of inflammatory conditions. The present invention is predicated in part on the identification of cells of the monocyte/macrophage lineage being critical for inflammation and, in particular, chronic inflammation. In accordance with the present invention, it is proposed that the reduction in levels of monocyte/macrophage-type cells and/or a reduction in the production of inflammatory and pro-inflammatory mediators by these cells, especially locally, is effective in reducing inflammatory conditions. The present invention further provides animal models useful for screening for reducing levels of monocyte/macrophage-type cells and/or reducing the production of inflammatory and pro-inflammatory mediators of these cells.
    Type: Grant
    Filed: May 8, 2001
    Date of Patent: November 25, 2008
    Assignee: The University of Melbourne
    Inventors: John Hamilton, Gary Peter Anderson, Ian Keith Campbell
  • METHOD OF TREATMENT AND AGENTS USEFUL FOR SAME
    Publication number: 20080131424
    Abstract: The present invention relates generally to a method for the treatment and prophylaxis of inflammatory conditions. The present invention is predicated in part on the identification of cells of the monocyte/macrophage lineage being critical for inflammation and, in particular, chronic inflammation. In accordance with the present invention, it is proposed that the reduction in levels of monocyte/macrophage-type cells and/or a reduction in the production of inflammatory and pro-inflammatory mediators by these cells, especially locally, is effective in reducing inflammatory conditions. The present invention further provides animal models useful for screening for reducing levels of monocyte/macrophage-type cells and/or reducing the production of inflammatory and pro-inflammatory mediators of these cells.
    Type: Application
    Filed: September 18, 2007
    Publication date: June 5, 2008
    Inventors: John HAMILTON, Gary Peter Anderson, Ian Keith Campbell
  • Method of treatment and agents useful for same
    Publication number: 20020010126
    Abstract: The present invention relates generally to a method for the treatment and prophylaxis of inflammatory conditions. The present invention is predicated in part on the identification of cells of the monocyte/macrophage lineage being critical for inflammation and, in particular, chronic inflammation. In accordance with the present invention, it is proposed that the reduction in levels of monocyte/macrophage-type cells and/or a reduction in the production of inflammatory and pro-inflammatory mediators by these cells, especially locally, is effective in reducing inflammatory conditions. The present invention further provides animal models useful for screening for reducing levels of monocyte/macrophage-type cells and/or reducing the production of inflammatory and pro-inflammatory mediators of these cells.
    Type: Application
    Filed: May 8, 2001
    Publication date: January 24, 2002
    Inventors: John Hamilton, Gary Peter Anderson